Literature DB >> 1886517

Genetic regulation of human immunodeficiency virus.

K Steffy1, F Wong-Staal.   

Abstract

Human immunodeficiency virus (HIV) has a complex life cycle in which both cellular and virus-encoded factors participate to determine the level of virus production. Two of the viral genes, tat and rev, are essential for virus replication and encode novel trans-activators that interact specifically with their cognate RNA target elements. Elucidation of their mechanisms of action is likely to expand our knowledge of gene regulation at transcriptional and posttranscriptional levels in the eukaryotic cell. Several viral genes (vif, vpu, and vpr) facilitate virus infection and/or release and may play a role in target cell tropism and infection in vivo. The functions of yet other viral genes (nef, vpt) remain unclear. Recent data also suggest that the tat gene product may have a role in HIV pathogenesis that goes beyond trans-activating virus expression. It can potentially impact on uninfected cells as a diffusible molecule and alter the growth of different cell types.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886517      PMCID: PMC372810          DOI: 10.1128/mr.55.2.193-205.1991

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  121 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

3.  Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.

Authors:  M J Selby; E S Bain; P A Luciw; B M Peterlin
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

4.  Tat protein from human immunodeficiency virus forms a metal-linked dimer.

Authors:  A D Frankel; D S Bredt; C O Pabo
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

5.  Structural and functional characterization of human immunodeficiency virus tat protein.

Authors:  S Ruben; A Perkins; R Purcell; K Joung; R Sia; R Burghoff; W A Haseltine; C A Rosen
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

6.  Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus.

Authors:  A D Friedman; S J Triezenberg; S L McKnight
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

7.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

8.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

Authors:  S Nakamura; S Z Salahuddin; P Biberfeld; B Ensoli; P D Markham; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

9.  Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

Authors:  S Z Salahuddin; S Nakamura; P Biberfeld; M H Kaplan; P D Markham; L Larsson; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

10.  Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.

Authors:  C E Hart; C Y Ou; J C Galphin; J Moore; L T Bacheler; J J Wasmuth; S R Petteway; G Schochetman
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

View more
  19 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  A role for RNA helicase A in post-transcriptional regulation of HIV type 1.

Authors:  J Li; H Tang; T M Mullen; C Westberg; T R Reddy; D W Rose; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  HIV Vpr controls CNS metabolism.

Authors:  Stacey Boyd; Yao Akpamagbo; Fatah Kashanchi
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

4.  Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses.

Authors:  G P Harrison; E Hunter; A M Lever
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

Authors:  R J Shattock; J S Friedland; G E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 6.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

7.  Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.

Authors:  M C Hannibal; D M Markovitz; N Clark; G J Nabel
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.

Authors:  K R Steffy; F Wong-Staal
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Inducible transcriptional activation of the human immunodeficiency virus long terminal repeat by protein kinase inhibitors.

Authors:  F L Brown; E Tahaoglu; G J Graham; J J Maio
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.

Authors:  M Witvrouw; R Pauwels; A M Vandamme; D Schols; D Reymen; N Yamamoto; J Desmyter; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.